3 Amazing Stocks That Are 60% Off Their Highs
The mini-crash of January has given investors the opportunity to buy some amazing healthcare companies at a discount. First we're going to take a look at Doximity (NYSE: DOCS), a telehealth powerhouse that is almost 60% off its highs. Next up is Novocure (NASDAQ: NVCR), a cancer specialist that has dropped 70% from its high point last year. And finally we're going across the pond to visit Affimed (NASDAQ: AFMD), a cancer drugmaker whose stock has dropped 65% from 2021.
These three biotech stocks have been slammed hard. But the biotech industry is often volatile, and you can find some exciting (and sometimes highly rewarding) opportunities when the market turns negative. Here is why we recommend Doximity, Novocure, and Affimed.
Image source: Getty Images.
Source Fool.com
